Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATENT PLUS: Riociguat + Sildenafil in PAH
NCT01179334Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of riociguat in pulmonary arterial hypertension (PAH), sponsored by Bayer. Started Aug 2010; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01179334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179334.